Security key
86150R107
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 71,106,152
- Total 13F value
- $2,314,555,481
- Share change
- +3,981,059
- Put/Call ratio
- 245%
- SEC-reported price per share
- $32.56
- Number of holders
- 195
- Value change
- +$130,892,958
- Number of buys
- 112
- Number of sells
- 79
- Shares outstanding
- 62,507,059
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
195
Top holders
10
STOK full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Stoke Therapeutics, Inc. SEC filings
Stoke Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 86150R107
Recent filing periods:
Ownership snapshot
Top reported holders of STOK - STOKE THERAPEUTICS INC - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RTW INVESTMENTS, LP
Disclosed value leader
RTW INVESTMENTS, LP
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G
13F
3/4/5
Lead comparable stake: 9.9%
13D/G row: RTW INVESTMENTS, LP
Showing 1-6 of 15 holder rows.
Quick read
RTW INVESTMENTS, LP leads the comparable SEC ownership view at 9.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens RTW INVESTMENTS, LP's linked filing trail.
Comparable ownership
Top 5
RTW INVESTMENTS, LP
9.9%
Lynx1 Capital Management LP
8.1%
BlackRock, Inc.
6.8%
Redmile Group, LLC
6.7%
MORGAN STANLEY
6.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13D/G
13F
Company
|
9.9%
|
$208,227,353
5,940,866 shares
|
+$22,110,697 | 31 Mar 2026 |
| Lynx1 Capital Management LP |
13F
13D/G
Company
|
8.1%
from 13D/G
|
$171,544,353
5,404,674 shares
|
— | 31 Dec 2025 |
| BlackRock, Inc. |
13F
13D/G
Company
|
6.8%
from 13D/G
|
$165,446,463
5,212,554 shares
|
— | 31 Dec 2025 |
| Redmile Group, LLC |
13D/G
13F
Company
|
6.7%
|
$145,952,406
4,164,120 shares
|
-$7,423,976 | 31 Mar 2026 |
| MORGAN STANLEY |
13F
13D/G
Company
|
6.5%
from 13D/G
|
$112,555,054
3,546,158 shares
|
— | 31 Dec 2025 |
| BAKER BROS. ADVISORS LP |
13F
13D/G
Company
|
5.8%
from 13D/G
|
$105,906,763
3,336,697 shares
|
— | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
195
Shares
71,106,152
Rows available
195
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q1 2026 Across Filers
Q1 2026 holders
195
Q1 2026 holders
195
Holder diff
0
| Investor | Q1 2026 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend